ARTICLE | Company News
Introgen manufacturing deal
March 8, 2001 8:00 AM UTC
Selective Genetics (San Diego, Calif.) will receive clinical grade manufacturing services from INGN for its soft tissue repair gene therapy programs, including a product to treat diabetic ulcers that ...